Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease

Journal of Crohn's and Colitis

Volumn 5, Issue 2, 2011, Pages 101-109

  Koutsoumpas, Andreas ^a,b   Polymeros, Dimitrios ^c   Tsiamoulos, Zacharias ^c   Smyk, Daniel ^a   Karamanolis, George ^c   Triantafyllou, Konstantinos ^c   Rigopoulou, E I ^e   Forbes, Alastair ^d   Vergani, Diego ^a   Bogdanos, Dimitrios P ^a   Ladas, Spiros D ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b IKA Athens Ongologic Hospital   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF THESSALY   (Greece)

Author keywords

Autoimmunity; Gastrointestinal; Infection; Inflammatory bowel disease; Mimicry

Indexed keywords

ANTIBODY; AUTOANTIGEN; CONNEXIN 37; CONNEXIN 37 ANTIBODY; PHOGRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BIOTINYLATION; CLINICAL ARTICLE; COXSACKIE VIRUS; CROHN DISEASE; DIABETES MELLITUS; ENTEROVIRUS; FEMALE; HUMAN; IMMUNOREACTIVITY; LACTOCOCCUS LACTIS; MALE; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; MYCOBACTERIUM TUBERCULOSIS; POLIOMYELITIS VIRUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RUBELLA VIRUS; SEQUENCE ALIGNMENT; SERODIAGNOSIS; ULCERATIVE COLITIS; UNITED STATES; VIRUS IMMUNITY;

ADULT; ANTIGEN-ANTIBODY REACTIONS; BACTERIAL PROTEINS; CONNEXINS; CROHN DISEASE; ENTEROVIRUS B, HUMAN; ENTEROVIRUS C, HUMAN; FEMALE; HUMANS; LACTOCOCCUS LACTIS; MALE; MIDDLE AGED; MOLECULAR MIMICRY; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS;

EID: 79953088253     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.10.009     Document Type: Article

References (54)

1. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134:577-594.
2. Bamias G., Cominelli F. Immunopathogenesis of inflammatory bowel disease: current concepts. Curr Opin Gastroenterol 2007, 23:365-369.
3. De Hertogh G., Aerssens J., Geboes K.P., Geboes K. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol 2008, 14:845-852.
4. Feller M., Huwiler K., Stephan R., Altpeter E., Shang A., Furrer H., et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007, 7:607-613.
5. Saruta M., Papadakis K.A. Why are cytokines targeted for biological therapy in IBD?. Inflamm Bowel Dis 2008, 14(Suppl. 2):S121-S122.
6. Braun J. In search of desire: mimicry, MAP, and Crohn's disease. Gastroenterology 2006, 131:312-314.
7. Ye J., Lee J.W., Presley L.L., Bent E., Wei B., Braun J., et al. Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis 2008, 14:1041-1050.
8. Velazquez P., Wei B., Braun J. Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin Immunopathol 2005, 26:453-462.
9. Sutton C.L., Kim J., Yamane A., Dalwadi H., Wei B., Landers C., et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 2000, 119:23-31.
10. Oldstone M.B. Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol 1989, 145:127-135.
11. Polymeros D., Bogdanos D.P., Day R., Arioli D., Vergani D., Forbes A. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology 2006, 131:85-96.
12. Bogdanos D., Pusl T., Rust C., Vergani D., Beuers U. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol 2008, 49:466-473.
13. Bogdanos D.P., Baum H., Grasso A., Okamoto M., Butler P., Ma Y., et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004, 40:31-39.
14. Bogdanos D.P., Baum H., Gunsar F., Arioli D., Polymeros D., Ma Y., et al. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol 2004, 39:981-987.
15. Bogdanos D.P., Baum H., Okamoto M., Montalto P., Sharma U.C., Rigopoulou E.I., et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005, 42:458-465.
16. Bogdanos D.P., Rigopoulou E.I. Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine 2006, 24:6173-6174.
17. Bogdanos D.P., Rigopoulou E.I. Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes. Diabetes Res Clin Pract 2007, 77:155-156.
18. Bogdanos D.P., Smith H., Ma Y., Baum H., Mieli-Vergani G., Vergani D. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 2005, 12:217-224.
19. Dalekos G.N., Bogdanos D.P., Neuberger J. Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?. Liver Int 2008, 28:426-428.
20. Gregorio G.V., Choudhuri K., Ma Y., Pensati P., Iorio R., Grant P., et al. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 2003, 133:404-413.
21. Koutsoumpas A., Mytilinaiou M., Polymeros D., Dalekos G.N., Bogdanos D.P. Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol 2009, 21:1220.
22. Ma Y., Bogdanos D.P., Hussain M.J., Underhill J., Bansal S., Longhi M.S., et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006, 130:868-882.
23. Ma Y., Meregalli M., Hodges S., Davies N., Bogdanos D.P., Fargion S., et al. Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease. Int J Immunopathol Pharmacol 2005, 18:173-182.
24. Muratori L., Bogdanos D.P., Muratori P., Lenzi M., Granito A., Ma Y., et al. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 2005, 3:595-603.
25. Goodenough D.A., Goliger J.A., Paul D.L. Connexins, connexons, and intercellular communication. Annu Rev Biochem 1996, 65:475-502.
26. Guttman J.A., Lin A.E., Li Y., Bechberger J., Naus C.C., Vogl A.W., et al. Gap junction hemichannels contribute to the generation of diarrhea during infectious enteric disease. Gut 2010, 59:218-226.
27. Handel A., Yates A., Pilyugin S.S., Antia R. Gap junction-mediated antigen transport in immune responses. Trends Immunol 2007, 28:463-466.
28. Neijssen J., Pang B., Neefjes J. Gap junction-mediated intercellular communication in the immune system. Prog Biophys Mol Biol 2007, 94:207-218.
29. Oviedo-Orta E., Hoy T., Evans W.H. Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations. Immunology 2000, 99:578-590.
30. Bracken S., Byrne G., Kelly J., Jackson J., Feighery C. Altered gene expression in highly purified enterocytes from patients with active coeliac disease. BMC Genomics 2008, 9:377.
31. Roivainen M. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. Int J Biochem Cell Biol 2006, 38:721-725.
32. Roivainen M., Klingel K. Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 2009, 52:995-996.
33. Pulli T., Lankinen H., Roivainen M., Hyypia T. Antigenic sites of coxsackievirus A9. Virology 1998, 240:202-212.
34. Pulli T., Roivainen M., Hovi T., Hyypia T. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. J Gen Virol 1998, 79(Pt 9):2249-2253.
35. Harkonen T., Paananen A., Lankinen H., Hovi T., Vaarala O., Roivainen M. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. J Med Virol 2003, 69:426-440.
36. Skarsvik S., Puranen J., Honkanen J., Roivainen M., Ilonen J., Holmberg H., et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes 2006, 55:996-1003.
37. Al-Hello H., Ylipaasto P., Smura T., Rieder E., Hovi T., Roivainen M. Amino acids of Coxsackie B5 virus are critical for infection of the murine insulinoma cell line, MIN-6. J Med Virol 2009, 81:296-304.
38. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1980, 1:514.
39. van 't Hof W., van Milligen F.J., Driedijk P.C., van den Berg M., Aalberse R.C. How to demonstrate specificity of antibody binding to synthetic peptides?. J Immunol Methods 1993, 161:273-275.
40. Bogdanos D.P., Mieli-Vergani G., Vergani D. Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter?. Clin Infect Dis 2005, 40:508-510.
41. Dai W., Field L.J., Rubart M., Reuter S., Hale S.L., Zweigerdt R., et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 2007, 43:504-516.
42. Bogdanos D.P., Gilbert D., Bianchi I., Leoni S., Mitry R.R., Ma Y., et al. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis 2004, 1:4.
43. Bogdanos D.P., Lenzi M., Okamoto M., Rigopoulou E.I., Muratori P., Ma Y., et al. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 2004, 17:83-92.
44. Bogdanos D.P., Bianchi I., Ma Y., Mitry R.R., Mieli-Vergani G., Vergani D. Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem 2004, 50:682-683. author reply 683-4.
45. Kerkar N., Choudhuri K., Ma Y., Mahmoud A., Bogdanos D.P., Muratori L., et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003, 170:1481-1489.
46. Papp M., Altorjay I., Norman G.L., Shums Z., Palatka K., Vitalis Z., et al. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis 2007, 13:984-992.
47. Boerma M., Forsberg L., Van Zeijl L., Morgenstern R., De Faire U., Lemne C., et al. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999, 246:211-218.
48. Kumari S.S., Varadaraj K., Valiunas V., Ramanan S.V., Christensen E.A., Beyer E.C., et al. Functional expression and biophysical properties of polymorphic variants of the human gap junction protein connexin37. Biochem Biophys Res Commun 2000, 274:216-224.
49. Kwak B.R., Mulhaupt F., Veillard N., Gros D.B., Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002, 22:225-230.
50. Wong C.W., Christen T., Kwak B.R. Connexins in leukocytes: shuttling messages?. Cardiovasc Res 2004, 62:357-367.
51. Brisset A.C., Isakson B.E., Kwak B.R. Connexins in vascular physiology and pathology. Antioxid Redox Signal 2009, 11:267-282.
52. Ramachandran S., Xie L.H., John S.A., Subramaniam S., Lal R. A novel role for connexin hemichannel in oxidative stress and smoking-induced cell injury. PLoS ONE 2007, 2:e712.
53. Park S.J., Lee K.S., Kim S.R., Min K.H., Lee K.Y., Choe Y.H., et al. Change of connexin 37 in allergen-induced airway inflammation. Exp Mol Med 2007, 39:629-640.
54. Roggenbuck D., Hausdorf G., Martinez-Gamboa L., Reinhold D., Büttner T., Jungblut P.R., et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009, 58:1620-1628.